Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.
Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
This prospective, non-randomised, open-label, clinical trial is conducting on polycystic
ovary syndrome (PCOS) subjects to compare the effects of two pituitary suppression regimens;
GnRH Agonist-Long Protocol and GnRH Antagonist-Flexible Protocol on clinical and
embryological IVF/ICSI outcomes, and on the follicular fluid levels of Placental Growth
Factor (PlGF); which is known for his pivotal role in the regulation of ovulation, embryo
development, and implantation